Suzhou

Global brands in China are increasing AI and robotics adoption to compete with local rivals and meet consumer demands for value. L’Oréal has expanded AI and automation use, including a smart operations center in Suzhou.

Chinese autonomous-driving start-up Momenta's HK$5.89 billion Hong Kong IPO was oversubscribed 414 times, attracting 210,000 subscription applications despite competing with five other IPOs. The Suzhou-based company's bookbuilding closed on Friday.

Chinese autonomous-driving start-up Momenta's HK$5.89 billion initial public offering in Hong Kong was oversubscribed 414 times, attracting nearly 210,000 subscription applications despite competing with five other IPOs. The company, based in Suzhou, closed its bookbuilding process on Friday.

A Chinese woman named Wang underwent a double eyelid surgery at Meixi Cosmetic Surgery Clinic in 2020, resulting in complications that left her unable to close her eyes and causing constant tears. She is now involved in legal disputes with the clinic over the botched procedure.

China’s Innovent Biologics has signed a $10.5 billion global collaboration with Pfizer to develop 12 cancer treatment programs. The deal includes an upfront payment of $650 million and potential milestone payments totaling up to $9.85 billion.

Innovent Biologics and Pfizer have signed a $10.5 billion collaboration to develop 12 cancer treatment programs. Innovent will receive an upfront payment of $650 million and up to $9.85 billion in milestone payments tied to development, regulatory, and commercial goals.

Zelos Technology, a Chinese autonomous driving company, claims its robovan fleet could generate twice as much revenue in Southeast Asia and the Middle East compared to China, emphasizing the need for overseas expansion to ensure profitability. The company, founded in Suzhou in 2021, highlights international scaling as critical for survival despite building the world's largest robovan fleet domestically.